Fig. 3From: Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysisForest plot showing biological and precision therapy utilization odds for all cancers (sub-grouped by drug class) for low compared to high socio-economic status. CI, confidence interval; SES, socio-economic statusBack to article page